within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05C_IrrigatingSolutions.B05CB10_ElectrolytesInCombinatio;

model ElectrolytesInCombinatio
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 0,
    adminDuration = 600,
    adminMass = 500 / 1000000,
    adminCount = 1,
    Vd = 0.001,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>ElectrolytesInCombination</td></tr><tr><td>ATC code:</td><td>B05CB10</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>0</td></tr>
    <tr><td>dosage:</td><td>500</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0</td><td></td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>This preparation contains combinations of electrolytes such as sodium, potassium, calcium, and magnesium, typically used for intravenous infusion to correct or prevent disturbances in electrolyte and fluid balance, especially in clinical situations such as dehydration, surgery, or intensive care. ATC code B05CB10 specifically refers to solutions containing combinations of electrolytes. These combinations are still widely used and are considered standard supportive therapy in modern medicine.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic parameters specific to electrolyte solutions (combinations) for B05CB10 could be found in the literature, as electrolytes do not follow traditional pharmacokinetic models used for most drugs. Electrolyte kinetics depend on physiological and pathophysiological processes rather than standard compartmental PK models.</p><h4>References</h4><ol><li><p>Bateman, RM, et al., &amp; Prandi, E (2016). 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. <i>Critical care (London, England)</i> 20(Suppl 2) 94–None. DOI:<a href=\"https://doi.org/10.1186/s13054-016-1208-6\">10.1186/s13054-016-1208-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27885969/\">https://pubmed.ncbi.nlm.nih.gov/27885969</a></p></li><li><p>Levitskaia, TG, et al., &amp; Thrall, KD (2010). Biomaterials for the decorporation of (85)Sr in the rat. <i>Health physics</i> 99(3) 394–400. DOI:<a href=\"https://doi.org/10.1097/HP.0b013e3181c4717d\">10.1097/HP.0b013e3181c4717d</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20699703/\">https://pubmed.ncbi.nlm.nih.gov/20699703</a></p></li><li><p>Yang, S, et al., &amp; Peachey, G (2021). Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN). <i>Clinical pharmacokinetics</i> 60(7) 887–896. DOI:<a href=\"https://doi.org/10.1007/s40262-021-00988-1\">10.1007/s40262-021-00988-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33598874/\">https://pubmed.ncbi.nlm.nih.gov/33598874</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.B.B05CB10 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end ElectrolytesInCombinatio;
